(lp0
S'Biotech Quick Pick: Insys Therapeutics Seeking Alpha - Mar 13, 2017 To determine if Insys Therapeutics is a long or short opportunity we will first translate the current stock price into a series of assumptions the market seems to be making about the future of the company. As evidenced by a 98% decline from highs ...Insys Therapeutics Inc  Set to Announce Earnings on Thursday - Chaffey BreezeRecent Update on Price Movements: Insys Therapeutics, Inc.  - Is stories'
p1
aS'SHAREHOLDER ALERT: Levi &amp; Korsinsky, LLP Notifies Investors of INSYS ... GuruFocus.com - Mar 20, 2017 To: All persons or entities who purchased or otherwise acquired securities of INSYS Therapeutics, Inc.   between February 23, 2016 and March 15, 2017.Insys Therapeutics Inc  Given Consensus Recommendation of Buy by ... - BNB Daily A Look at 2 Trending Stocks: INSYS Therapeutics, Inc. , PharMerica ... - Post Analyst'
p2
aS"Analyst's Proposition on INSYS Therapeutics, Inc. , Boston Properties ... The USA Commerce - 19 hours ago INSYS Therapeutics, Inc.  share price decreased in the last trading session with a previous 52-week high of $20.98."
p3
aS'Insys Therapeutics Announces Delay in the Release of its Fourth Quarter and ... GlobeNewswire  - Mar 15, 2017 PHOENIX, March 15, 2017  -- Insys Therapeutics, Inc.   today announced that the Company will delay the release of its financial results for the fourth quarter and full year 2016.INSYS Therapeutics, Inc.  investors have generally bought the stock ... - Post AnalystStock Returns: INSYS Therapeutics Inc  versus MacroGenics Inc ... - CML News'
p4
aS"Glancy Prongay &amp; Murray LLP Commences Investigation on Behalf of Insys ... Yahoo Finance - Mar 16, 2017 Glancy Prongay &amp; Murray LLP  is investigating potential claims on behalf of investors of Insys Therapeutics, Inc.   concerning the Company and its officers' possible violations of federal securities laws."
p5
aS'SHAREHOLDER ALERT: Bronstein, Gewirtz &amp; Grossman, LLC Announces Investigation ... Yahoo Finance - Mar 16, 2017 NEW YORK, March 16, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz &amp; Grossman, LLC is investigating potential claims on behalf of purchasers of the INSYS Therapeutics, Inc.  . Such investors are advised&nbsp;...'
p6
aS'EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action ... Yahoo Finance - Mar 17, 2017 Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Insys Therapeutics, Inc. securities  from February 23, 2016 through March 15, 2017, inclusive . The ...'
p7
aS'SHAREHOLDER ALERT: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Investors of ... GlobeNewswire  - Mar 21, 2017 NEW YORK, March 21, 2017  -- Attorney Advertising -- Bronstein, Gewirtz &amp; Grossman, LLC notifies investors that a class action lawsuit has been filed against INSYS Therapeutics, Inc.   and&nbsp;...'
p8
aS"Insys Therapeutics Inc  Might Be A Discount At Current Prices Insider Financial - Feb 22, 2017 Throughout December last year, Insys Therapeutics Inc  flat lined around $9 a share. Despite continued effort by management to maintain a positive news flow, and in turn, to buoy positive sentiment, the company couldn't break the $10 a&nbsp;...Insys Therapeutics Inc.  Moves Higher on Volume Spike for February 21 - Equities.comLet's Get Complex With INSYS Therapeutics, Inc.  - Post Analyst"
p9
aS'SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ... PR Newswire  - Mar 16, 2017 NEW YORK, March 16, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of INSYS Therapeutics, Inc.  . Such investors are advised to contact Robert S. Willoughby at&nbsp;...'
p10
a.